GlassScriptPhysician profile
Kathleen E Bren
NPI 1154717387
$1,444.49
in general payments reported to CMS, 2019-2025
20 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $122 · 2021: $74.14 · 2022: $356 · 2023: $383 · 2024: $191 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $244.48 | 2019-2024 | Veozah |
| Abbvie INC. | $226.28 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $151.62 | 2019-2025 | Acessa Provu System, Coolseal Generator, Aptima |
| Coopersurgical, INC. | $139.96 | 2019-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Astellas Pharma Global Development | $118.44 | 2023 | Veozah |
| Pfizer INC. | $100.88 | 2020-2024 | |
| Ethicon US, LLC | $78.82 | 2025 | Enseal |
| Myovant Sciences INC. | $67.69 | 2022 | |
| Millicent US INC | $44.08 | 2019-2020 | |
| Becton, Dickinson and Company | $42.07 | 2024-2025 | Bd Max System, Bd Max Instrument |
| Bayer Healthcare Pharmaceuticals INC. | $40.20 | 2019-2022 | |
| Aesculap, INC. | $35.47 | 2019 | |
| Sage Therapeutics, LLC | $35.38 | 2024 | |
| Sumitomo Pharma America, INC. | $22.93 | 2024 | Myfembree |
| Biogen, INC. | $19.48 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.29 | 2022 | |
| Aspira Women'S Health INC | $16.46 | 2023 | Ova1 |
| Therapeuticsmd, INC. | $16.07 | 2019 | |
| Minerva Surgical, INC | $13.44 | 2022 | |
| Olympus America INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Bren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.